众兴菌业(002772) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥622,909,683.16, representing a 27.60% increase compared to ¥488,191,571.56 in the same period last year[4] - Net profit attributable to shareholders reached ¥198,103,761.13, a significant increase of 1,298.75% from ¥14,162,895.37 in the previous year[4] - Basic earnings per share rose to ¥0.5042, reflecting a 1,277.60% increase from ¥0.0366 in the same period last year[4] - The net profit for Q1 2023 was CNY 199,037,157.91, a significant increase from CNY 14,184,202.07 in Q1 2022, representing a growth of approximately 1,300%[21] - Operating profit for the quarter reached CNY 199,064,639.86, compared to CNY 15,109,366.97 in the same period last year, indicating a substantial improvement[21] - The total comprehensive income for the quarter was CNY 199,037,157.91, compared to CNY 14,184,202.07 in the same quarter last year, reflecting a strong performance[22] Cash Flow - The net cash flow from operating activities was ¥261,700,254.55, up 103.90% from ¥128,350,085.16 year-on-year[4] - Cash flow from operating activities was CNY 261,700,254.55, up from CNY 128,350,085.16 year-over-year, reflecting a growth of about 104%[23] - The company reported a net cash flow from investment activities of ¥21,517,700.00, a turnaround from a negative cash flow of ¥192,884,000.00 in the previous year[11] - Investment activities generated a net cash inflow of CNY 21,517,745.22, a recovery from a net outflow of CNY 192,884,044.82 in the previous year[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥7,146,958,788.33, an 8.80% increase from ¥6,569,141,307.16 at the end of the previous year[4] - Total assets as of March 31, 2023, amounted to RMB 7,146,958,788.33, up from RMB 6,569,141,307.16 at the beginning of the year, indicating a growth of 8.8%[18] - The company’s total liabilities increased to RMB 3,561,891,389.08 from RMB 3,184,469,769.92, reflecting a rise of 11.8%[18] Borrowings and Financial Expenses - Short-term borrowings increased by 116.44% to ¥325,000,000.00, primarily to meet operational needs[9] - Short-term borrowings rose to RMB 325,000,000.00 from RMB 150,156,666.67, representing a 116.5% increase[17] - Financial expenses decreased by 42.38% to ¥7,379,900.00, attributed to the timing of new borrowings[10] - The company raised CNY 495,000,000.00 through borrowings in Q1 2023, compared to CNY 321,000,000.00 in Q1 2022, indicating a 54% increase in financing activities[25] Profitability Metrics - The weighted average return on equity was 5.69%, up from 0.43% in the same period last year, indicating improved profitability[4] - Gross profit margin improved to approximately 32.3% in Q1 2023, compared to 12.2% in the same period last year[20] Government Subsidies and R&D - The company received government subsidies amounting to ¥5,739,818.61, which were directly recorded in the current period's profit and loss[6] - Research and development expenses for Q1 2023 were RMB 2,828,174.23, up from RMB 2,533,808.43, indicating a growth of 11.6% year-over-year[20] Cash and Inventory - Cash and cash equivalents increased significantly to RMB 2,015,684,734.90 from RMB 1,326,172,476.93, marking a growth of 52%[16] - Cash and cash equivalents at the end of the period totaled CNY 2,015,684,734.90, an increase from CNY 1,687,876,702.27 at the end of Q1 2022[25] - Inventory levels slightly decreased to RMB 1,242,139,666.64 from RMB 1,255,493,756.92, a decline of 1.1%[17]